Spurious Drugs Case: Baddi Firm Owner Fails To Join Probe

Solan : Mukesh Saini, proprietor of Magnatek Enterprises, a pharmaceutical firm allegedly involved in the production of spurious drugs, failed to join the investigation at Baddi today.

The authorities sealed the unit on July 16 after seizing spurious drugs manufactured in violation of the Drugs and Cosmetics Act. The officials will inspect the premises in his presence.

CCTV footage obtained by drug officials showed him leaving the firm premises in a hurry around 8 pm on Sunday soon after a consignment was seized at the godown of a transport company.

He had reportedly received a call from the staff of the transport company about the seizure following which few other employees also made a hasty retreat on a bike while few lower-rung employees were left working in the unit.

Drugs Controller Navneet Marwaha said proprietor of Magnatek Enterprises Mukesh Saini failed to join the probe over the past two days. He has been granted the last opportunity tomorrow following which appropriate action would be taken against him.

With water-logging plaguing Delhi, the drug authorities are yet to verify whether a wholesale chemist in central Delhi had received any stock of spurious drugs manufactured at the Magnatek unit in the past.

Such a stock would be withdrawn from the market. The officials were verifying the other drug consignments sent by the firm to Chandigarh and other places.

It has been observed that wholesale traders from other states have direct links with the manufacturers at Baddi.

Related Posts

  • Pharma
  • December 21, 2024
  • 127 views
Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Bengaluru: The Karnataka government has initiated prosecution against Paschim Banga Pharmaceuticals after five women died following C-section deliveries in Ballari district, where they were administered the company’s IV fluid. Health Minister…

  • Pharma
  • December 21, 2024
  • 181 views
NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

New Delhi:  The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling price fixation of 13 scheduled formulations, retail price fixation of 65 new drugs against applications from individual companies, and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Telangana DCA Cracks Down On Illegal Drug Practices

Telangana DCA Cracks Down On Illegal Drug Practices

Pune: Two Arrested For Selling Illegal Steroid Injections In Gyms

Pune: Two Arrested For Selling Illegal Steroid Injections In Gyms

Serum To Make Chikungunya Vaccine In India

Serum To Make Chikungunya Vaccine In India